{
  "template_id": "PSUR_COMPREHENSIVE_EU_MDR_MDCG_2022_21",
  "name": "Comprehensive PSUR Template - EU MDR 2017/745 with MDCG 2022-21 Annex I",
  "version": "3.0",
  "created_date": "2025-01-25",
  "updated_date": "2025-01-25",
  "jurisdiction_scope": [
    "EU_MDR",
    "UK_MDR",
    "UKCA"
  ],
  "device_class_applicability": [
    "CLASS_I",
    "CLASS_IIA",
    "CLASS_IIB",
    "CLASS_III"
  ],
  "regulatory_basis": {
    "primary": "EU MDR 2017/745 Article 86",
    "template_standard": "MDCG 2022-21 Template for PSURs (Annex I)",
    "supporting": [
      "ISO 13485:2016 Section 8.2.1",
      "MEDDEV 2.12/1 Rev 8 Guidelines on Post-Market Surveillance",
      "IMDRF Adverse Event Terminology and Coding"
    ]
  },
  "template_metadata": {
    "author": "Regulatory AI System",
    "purpose": "Systematic periodic safety update reporting for medical devices under EU MDR with MDCG 2022-21 standardized structure",
    "update_frequency": "Annual or biennial per device risk classification",
    "estimated_completion_time_hours": 45,
    "quality_review_required": true,
    "notified_body_submission_required": true,
    "mdcg_annex_i_compliant": true
  },
  "slots": [
    {
      "slot_id": "mdcg_toc",
      "slot_name": "Table of Contents",
      "section_number": "TOC",
      "mdcg_reference": "MDCG.ANNEXI.TOC",
      "description": "Automatically generated table of contents with section numbers, titles, and page numbers",
      "evidence_requirements": [
        "document_structure"
      ],
      "regulatory_reference": "MDCG 2022-21 Annex I - Standard structure",
      "required": true,
      "data_type": "auto_generated",
      "completion_priority": 15,
      "estimated_time_minutes": 10,
      "agent_assignment": "document_formatter",
      "generation_rules": {
        "format": "Numbered list with page references",
        "depth": "Two levels (section and subsection)",
        "style": "Section titles bold, subsections regular",
        "page_numbering": "Automatic from document processor"
      },
      "standard_structure": [
        "Cover Page",
        "Table of Contents",
        "A. Executive Summary",
        "  A.1 Previous PSUR Actions Status",
        "  A.2 Notified Body Review Status",
        "  A.3 Data Collection Period Changes",
        "  A.4 Benefit-Risk Assessment Conclusion",
        "B. Device Description and Intended Purpose",
        "C. Sales and Distribution Data",
        "  Table 1. Annual Number of Devices Sold by Region",
        "D. Information on Serious Incidents",
        "  Table 2. Serious Incidents by Medical Device Problem (IMDRF Annex A)",
        "  Table 3. Serious Incidents by Investigation Conclusion (IMDRF Annex C)",
        "  Table 4. Health Effects by Investigation Conclusion (IMDRF Annex D)",
        "  Table 5. Serious Incidents by Region and Severity",
        "E. Customer Feedback",
        "  Table 6. Customer Feedback by Source and Type",
        "F. Product Complaint Types, Counts, and Rates",
        "  Table 7. Complaint Analysis by Type",
        "  Table 8. Complaints by Region and Seriousness",
        "G. Information from Trend Reporting",
        "  Table G.1. Monthly Complaint Rate Trending with SPC Limits",
        "  Table G.2. Event Category Disproportionality Analysis (PRR)",
        "  Table G.3. Current vs. Baseline Period Statistical Comparison",
        "  Table G.4. Threshold Breach Assessment and Actions",
        "H. Information from Field Safety Corrective Actions",
        "  Table H.1. FSCA Summary Table",
        "I. Corrective and Preventive Actions",
        "  Table I.1. CAPA Summary Table",
        "J. Scientific Literature Review",
        "K. Review of External Databases and Registries",
        "  Table 10. External Database Adverse Events Summary",
        "L. Post-Market Clinical Follow-Up",
        "  Table 11. PMCF Activities and Findings",
        "M. Conclusions",
        "  M(a). Benefit-Risk Determination",
        "  M(b). Achievement of Intended Benefits",
        "  M(c). Data Limitations",
        "  M(d). New or Emerging Risks and Benefits",
        "  M(e). Actions Taken or Recommended",
        "  M(f). Overall Performance and Safety Conclusion",
        "Appendices (if applicable)"
      ],
      "quality_checks": [
        "All section numbers match document",
        "Page numbers accurate",
        "All required sections present",
        "Table titles match actual tables"
      ],
      "output_format": "Auto-generated formatted list",
      "human_review_required": false
    },
    {
      "slot_id": "cover_page",
      "slot_name": "Cover Page",
      "section_number": "Cover",
      "description": "Administrative information identifying the device, manufacturer, reporting period, and submission metadata",
      "evidence_requirements": [
        "device_registry_record",
        "certificate_of_conformity",
        "manufacturer_registration",
        "notified_body_designation",
        "basic_udi_di"
      ],
      "regulatory_reference": "EU MDR Article 86(1), MDCG 2022-21 Section 1",
      "required": true,
      "data_type": "structured_metadata",
      "completion_priority": 1,
      "estimated_time_minutes": 30,
      "sub_fields": [
        {
          "field_id": "device_name",
          "field_name": "Device Name and Variants",
          "data_type": "text",
          "validation": "required, max_length:200",
          "example": "Fischer Cone Biopsy Excisor (all catalog numbers)"
        },
        {
          "field_id": "basic_udi_di",
          "field_name": "Basic UDI-DI",
          "data_type": "text",
          "validation": "required, format:udi_di",
          "example": "0886982104321XYZ"
        },
        {
          "field_id": "device_classification",
          "field_name": "Device Classification",
          "data_type": "enum",
          "allowed_values": [
            "CLASS_I",
            "CLASS_IIA",
            "CLASS_IIB",
            "CLASS_III"
          ],
          "validation": "required"
        },
        {
          "field_id": "manufacturer_name",
          "field_name": "Manufacturer Name",
          "data_type": "text",
          "validation": "required"
        },
        {
          "field_id": "manufacturer_address",
          "field_name": "Manufacturer Address",
          "data_type": "address",
          "validation": "required"
        },
        {
          "field_id": "srn_number",
          "field_name": "Single Registration Number (SRN)",
          "data_type": "text",
          "validation": "optional, format:srn"
        },
        {
          "field_id": "notified_body",
          "field_name": "Notified Body",
          "data_type": "structured",
          "validation": "required",
          "sub_fields": [
            "name",
            "number",
            "certificate_number",
            "certificate_expiry"
          ]
        },
        {
          "field_id": "reporting_period",
          "field_name": "Data Collection Period",
          "data_type": "date_range",
          "validation": "required, format:DD_MONTH_YYYY",
          "example": "01 January 2024 to 31 December 2025"
        },
        {
          "field_id": "psur_reference",
          "field_name": "PSUR Reference Number",
          "data_type": "text",
          "validation": "required",
          "example": "PSUR094 Rev A"
        },
        {
          "field_id": "submission_date",
          "field_name": "Submission Date",
          "data_type": "date",
          "validation": "required"
        },
        {
          "field_id": "uk_responsible_person",
          "field_name": "UK Responsible Person (if UKCA)",
          "data_type": "structured",
          "validation": "conditional:uk_market",
          "sub_fields": [
            "name",
            "address",
            "registration_number"
          ]
        }
      ],
      "quality_checks": [
        "All device identifiers match EUDAMED registration",
        "Certificate number valid and not expired",
        "Reporting period aligns with PMS Plan requirements"
      ],
      "agent_assignment": null,
      "human_review_required": true
    },
    {
      "slot_id": "section_a_executive_summary",
      "slot_name": "Section A - Executive Summary",
      "section_number": "A",
      "description": "High-level summary of PSUR findings, benefit-risk determination, and key actions. Most critical section for regulatory review.",
      "evidence_requirements": [
        "sales_data_summary",
        "complaint_summary",
        "serious_incident_summary",
        "trending_conclusions",
        "benefit_risk_assessment"
      ],
      "regulatory_reference": "EU MDR Article 86(3), MDCG 2022-21 Section A",
      "required": true,
      "data_type": "narrative",
      "completion_priority": 10,
      "estimated_time_minutes": 120,
      "agent_assignment": "executive_summary_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_executive_summary.md",
      "sub_sections": [
        {
          "subsection_id": "a1_previous_psur_actions",
          "subsection_name": "Previous PSUR Actions Status",
          "description": "Summary of actions from previous PSUR and completion status",
          "required": true,
          "checkbox_fields": [
            "completed",
            "in_progress",
            "not_started",
            "not_applicable"
          ],
          "narrative_length": "1-3 sentences"
        },
        {
          "subsection_id": "a2_notified_body_review",
          "subsection_name": "Notified Body Review Status",
          "description": "Status of Notified Body review of previous PSUR and any actions taken",
          "required": true,
          "checkbox_fields": [
            "yes",
            "no",
            "n_a"
          ],
          "narrative_length": "1-2 sentences"
        },
        {
          "subsection_id": "a3_period_changes",
          "subsection_name": "Data Collection Period Changes",
          "description": "Whether data collection period was changed from planned period and justification",
          "required": true,
          "checkbox_fields": [
            "yes",
            "no"
          ],
          "narrative_length": "1-3 sentences (if changed); 1 sentence (if not changed)"
        },
        {
          "subsection_id": "a4_benefit_risk",
          "subsection_name": "Benefit-Risk Assessment Conclusion",
          "description": "Definitive conclusion on whether benefit-risk profile has been adversely impacted, with supporting data from all PMS sources",
          "required": true,
          "checkbox_fields": [
            "unchanged",
            "adversely_impacted"
          ],
          "narrative_length": "2-4 paragraphs (200-400 words)",
          "critical_elements": [
            "Units distributed during period",
            "Complaint count and rate with RACT comparison",
            "Serious incident summary with attribution",
            "Key findings from literature, databases, PMCF",
            "Explicit conclusion statement"
          ]
        }
      ],
      "quality_checks": [
        "Checkbox selections made for all subsections",
        "Benefit-risk conclusion clearly stated (UNCHANGED or ADVERSELY IMPACTED)",
        "Specific quantitative data included (units, rates, counts)",
        "All PMS data sources referenced",
        "No citation markers in narrative"
      ],
      "output_format": "Clean narrative prose with checkbox selections, no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGHEST"
    },
    {
      "slot_id": "section_b_device_description",
      "slot_name": "Section B - Device Description and Intended Purpose",
      "section_number": "B",
      "description": "Comprehensive device technical description, classification, regulatory status, intended purpose, indications, and grouping justification (if applicable)",
      "evidence_requirements": [
        "technical_documentation",
        "certificate_of_conformity",
        "instructions_for_use",
        "risk_management_file_summary",
        "clinical_evaluation_report_summary",
        "device_grouping_rationale"
      ],
      "regulatory_reference": "EU MDR Annex III Section 1, Article 86 requirements for device identification",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 2,
      "estimated_time_minutes": 90,
      "agent_assignment": "device_description_agent",
      "sub_sections": [
        {
          "subsection_id": "b1_device_identification",
          "subsection_name": "Device Identification",
          "description": "Complete device identification including all variants, catalog numbers, UDI-DI",
          "required": true,
          "fields": [
            "device_name_all_variants",
            "catalog_numbers_all",
            "basic_udi_di",
            "gmdn_code",
            "nomenclature_codes"
          ]
        },
        {
          "subsection_id": "b2_classification",
          "subsection_name": "Device Classification and Regulatory Status",
          "description": "EU MDR classification, rule applied, other jurisdiction classifications, certificate status",
          "required": true,
          "fields": [
            "eu_classification_rule",
            "uk_classification_rule",
            "us_premarket_status",
            "certificate_number",
            "certificate_expiry",
            "certificate_status"
          ],
          "multi_product_support": true
        },
        {
          "subsection_id": "b3_technical_description",
          "subsection_name": "Technical Description",
          "description": "Multi-paragraph technical description covering physical characteristics, materials, sterility, packaging",
          "required": true,
          "narrative_length": "3-5 paragraphs per product",
          "paragraph_structure": [
            "Physical description and principle of operation",
            "Materials and biocompatibility",
            "Sterility and packaging",
            "Accessories and ancillary products"
          ],
          "multi_product_support": true
        },
        {
          "subsection_id": "b4_intended_purpose",
          "subsection_name": "Intended Purpose and Indications",
          "description": "Statement of intended purpose, clinical indications, contraindications, target population",
          "required": true,
          "fields": [
            "intended_purpose_statement",
            "indications_for_use",
            "contraindications",
            "target_patient_population",
            "warnings_precautions_summary"
          ],
          "multi_product_support": true
        },
        {
          "subsection_id": "b5_regulatory_history",
          "subsection_name": "Regulatory History and Approvals",
          "description": "Chronological approval history across jurisdictions",
          "required": true,
          "fields": [
            "first_ce_marking_date",
            "current_certificate_date",
            "fda_approval_date_type",
            "other_jurisdictions_approvals"
          ],
          "multi_product_support": true
        },
        {
          "subsection_id": "b6_grouping_justification",
          "subsection_name": "Grouping Justification (if multi-product PSUR)",
          "description": "Justification per Article 86 for grouping multiple products in single PSUR",
          "required": "conditional:multi_product",
          "fields": [
            "grouping_rationale_article_86",
            "same_cer_checkbox",
            "same_notified_body_checkbox",
            "leading_device_identification",
            "leading_device_rationale",
            "grouping_changes_since_previous"
          ],
          "quality_checks": [
            "All Article 86 grouping criteria addressed",
            "Leading device clearly identified and justified",
            "Same CER and same NB confirmed with checkboxes"
          ]
        }
      ],
      "quality_checks": [
        "All device variants and catalog numbers listed",
        "Classification rules correctly cited",
        "Intended purpose matches approved labeling",
        "Multi-product grouping justified if applicable",
        "Technical description sufficient for device understanding"
      ],
      "output_format": "Narrative with embedded checkboxes for grouping section",
      "human_review_required": true
    },
    {
      "slot_id": "section_c_sales_distribution",
      "slot_name": "Section C - Sales and Distribution Data",
      "section_number": "C",
      "mdcg_reference": "MDCG.ANNEXI.SALES_TABLE",
      "description": "Comprehensive sales volumes by region over multiple periods, including market introduction history and distribution estimates (population exposure)",
      "evidence_requirements": [
        "sales_data_by_region",
        "sales_data_historical_periods",
        "market_introduction_dates",
        "distribution_channel_data",
        "patient_exposure_estimates"
      ],
      "regulatory_reference": "EU MDR Article 86 - Population exposure data required for rate calculations; MDCG 2022-21 Annex I Sales Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 3,
      "estimated_time_minutes": 60,
      "agent_assignment": "sales_distribution_agent",
      "sub_sections": [
        {
          "subsection_id": "c1_market_history",
          "subsection_name": "Market Introduction and History",
          "description": "Narrative describing when device first marketed, geographic expansion, significant milestones",
          "required": true,
          "narrative_length": "2-3 paragraphs per product",
          "multi_product_support": true,
          "paragraph_structure": [
            "Initial market introduction (year, region)",
            "Device characteristics and evolution",
            "CE marking and regulatory history"
          ]
        },
        {
          "subsection_id": "c2_sales_tables",
          "subsection_name": "Table 1: Exposure Table — Units Placed on Market by Region",
          "mdcg_reference": "MDCG.ANNEXI.SALES_TABLE",
          "description": "Tabular sales data by region for current and preceding periods with exposure estimates",
          "required": true,
          "table_type": "sales_by_region",
          "multi_product_support": true,
          "table_structure": {
            "table_id": "table_1_sales_exposure",
            "table_name": "Table 1. Annual Number of Devices Sold by Region (Population Exposure)",
            "columns": [
              {
                "column_id": "region",
                "column_name": "Region",
                "data_type": "text",
                "alignment": "left",
                "description": "Geographic region or country"
              },
              {
                "column_id": "preceding_period_1",
                "column_name": "Period 1 (YYYY-YYYY)",
                "data_type": "integer",
                "alignment": "right",
                "description": "Units distributed in first preceding period"
              },
              {
                "column_id": "preceding_period_2",
                "column_name": "Period 2 (YYYY-YYYY)",
                "data_type": "integer",
                "alignment": "right",
                "description": "Units distributed in second preceding period"
              },
              {
                "column_id": "preceding_period_3",
                "column_name": "Period 3 (YYYY-YYYY)",
                "data_type": "integer",
                "alignment": "right",
                "description": "Units distributed in third preceding period (optional)"
              },
              {
                "column_id": "current_period",
                "column_name": "Current Period (YYYY-YYYY)",
                "data_type": "integer",
                "alignment": "right",
                "description": "Units distributed in current surveillance period"
              },
              {
                "column_id": "percent_global",
                "column_name": "% Global",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%",
                "description": "Percentage of worldwide distribution (current period)"
              },
              {
                "column_id": "exposure_estimate",
                "column_name": "Estimated Exposure*",
                "data_type": "text",
                "alignment": "left",
                "description": "Optional: Patient/procedure count estimate",
                "required": false
              }
            ],
            "standard_regions": [
              "Australia",
              "Brazil",
              "Canada",
              "China",
              "EEA+TR+XI",
              "Israel",
              "Japan",
              "Russian_Federation",
              "Serbia",
              "UK",
              "United_States",
              "Rest_of_World",
              "Worldwide"
            ],
            "formatting": {
              "numbers": "comma_separated_or_no_separator",
              "percentages": "X.XXX% (3 decimals)",
              "alignment": "region_left_numbers_right",
              "total_row": "bold_worldwide",
              "exposure_footnote": "* Estimated patient/procedure exposure if different from units distributed (e.g., multi-use devices)"
            }
          }
        },
        {
          "subsection_id": "c3_sales_charts",
          "subsection_name": "Sales Chart Descriptions",
          "description": "Narrative descriptions of yearly and monthly sales trends with data analysis",
          "required": true,
          "multi_product_support": true,
          "chart_types": [
            {
              "chart_id": "yearly_sales",
              "description_format": "State all data points, identify trend (upward/downward/stable), calculate and state average",
              "length": "2-3 sentences"
            },
            {
              "chart_id": "monthly_sales",
              "description_format": "State all monthly values, identify highest and lowest, calculate average, describe fluctuation pattern",
              "length": "2-3 sentences"
            }
          ]
        }
      ],
      "quality_checks": [
        "Worldwide totals match sum of all regions",
        "Percentages sum to 100.000%",
        "All periods have consistent regional breakdown",
        "Multi-product tables have separate entries per product",
        "Chart descriptions include actual data values and trends",
        "Exposure estimates provided if different from units (e.g., multi-use devices)"
      ],
      "output_format": "Narrative with embedded Table 1 (sales/exposure), no inline citations",
      "human_review_required": false
    },
    {
      "slot_id": "section_d_serious_incidents",
      "slot_name": "Section D - Information on Serious Incidents",
      "section_number": "D",
      "mdcg_reference": "MDCG.ANNEXI.SERIOUS_INCIDENTS_TABLE_IMDRF",
      "description": "Comprehensive documentation of all serious incidents including IMDRF coding, patient outcomes, investigation conclusions, and regulatory reporting status",
      "evidence_requirements": [
        "serious_incident_reports",
        "imdrf_coding_data",
        "investigation_reports",
        "regulatory_notification_records",
        "patient_outcome_data"
      ],
      "regulatory_reference": "EU MDR Articles 87, 88; MDCG 2020-10/11; IMDRF Adverse Event Terminology; MDCG 2022-21 Annex I SI Tables",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 4,
      "estimated_time_minutes": 90,
      "agent_assignment": "safety_narrative_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_safety_analysis.md",
      "sub_sections": [
        {
          "subsection_id": "d1_si_summary",
          "subsection_name": "Serious Incident Summary",
          "description": "Opening statement on total serious incidents, breakdown by outcome, comparison to previous period",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "required_elements": [
            "Total SI count",
            "Deaths count",
            "Serious injuries count",
            "Other serious deterioration count",
            "Comparison to previous period"
          ]
        },
        {
          "subsection_id": "d2_imdrf_classification",
          "subsection_name": "IMDRF Classification Tables",
          "mdcg_reference": "MDCG.ANNEXI.SERIOUS_INCIDENTS_TABLE_IMDRF",
          "description": "Structured tables classifying SIs by IMDRF Annexes A, C, D",
          "required": "conditional:si_count_greater_than_zero",
          "table_types": [
            {
              "table_id": "table_2_imdrf_annex_a",
              "table_name": "Table 2. Serious Incidents by Medical Device Problem (IMDRF Annex A)",
              "mdcg_standard": true,
              "columns": [
                {
                  "column_id": "problem_code",
                  "column_name": "IMDRF Problem Code",
                  "data_type": "text",
                  "alignment": "left"
                },
                {
                  "column_id": "problem_description",
                  "column_name": "Problem Description",
                  "data_type": "text",
                  "alignment": "left"
                },
                {
                  "column_id": "count",
                  "column_name": "Count",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "percentage",
                  "column_name": "Percentage",
                  "data_type": "percentage",
                  "alignment": "right",
                  "format": "XX.X%"
                }
              ],
              "sort": "descending_by_count",
              "total_row": true
            },
            {
              "table_id": "table_3_imdrf_annex_c",
              "table_name": "Table 3. Serious Incidents by Investigation Conclusion (IMDRF Annex C)",
              "mdcg_standard": true,
              "columns": [
                {
                  "column_id": "investigation_finding",
                  "column_name": "Investigation Finding/Conclusion",
                  "data_type": "text",
                  "alignment": "left"
                },
                {
                  "column_id": "count",
                  "column_name": "Count",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "percentage",
                  "column_name": "Percentage",
                  "data_type": "percentage",
                  "alignment": "right",
                  "format": "XX.X%"
                }
              ],
              "predefined_categories": [
                "Device-related",
                "Procedure-related",
                "Patient factor",
                "Indeterminate",
                "Under investigation"
              ],
              "total_row": true
            },
            {
              "table_id": "table_4_imdrf_annex_d",
              "table_name": "Table 4. Health Effects by Investigation Conclusion (IMDRF Annex D)",
              "mdcg_standard": true,
              "table_type": "matrix",
              "columns": [
                {
                  "column_id": "health_impact",
                  "column_name": "Health Impact (IMDRF Annex D)",
                  "data_type": "text",
                  "alignment": "left"
                },
                {
                  "column_id": "device_related",
                  "column_name": "Device-Related",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "procedure_related",
                  "column_name": "Procedure-Related",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "patient_factor",
                  "column_name": "Patient Factor",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "indeterminate",
                  "column_name": "Indeterminate",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "total",
                  "column_name": "TOTAL",
                  "data_type": "integer",
                  "alignment": "right"
                }
              ],
              "predefined_rows": [
                "Death",
                "Permanent impairment",
                "Temporary injury requiring intervention",
                "No patient harm"
              ],
              "total_row": true,
              "total_column": true
            },
            {
              "table_id": "table_5_si_region_severity",
              "table_name": "Table 5. Serious Incidents by Region and Severity",
              "mdcg_standard": false,
              "description": "Optional table showing geographic distribution of SIs by severity",
              "required": false,
              "columns": [
                {
                  "column_id": "region",
                  "column_name": "Region",
                  "data_type": "text",
                  "alignment": "left"
                },
                {
                  "column_id": "death",
                  "column_name": "Death",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "serious_injury",
                  "column_name": "Serious Injury",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "other_serious",
                  "column_name": "Other Serious",
                  "data_type": "integer",
                  "alignment": "right"
                },
                {
                  "column_id": "total",
                  "column_name": "Total",
                  "data_type": "integer",
                  "alignment": "right"
                }
              ]
            }
          ]
        },
        {
          "subsection_id": "d3_patient_outcomes",
          "subsection_name": "Patient Outcomes and Clinical Analysis",
          "description": "Detailed clinical description of patient outcomes, medical interventions required, attribution analysis",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "required_elements": [
            "Clinical outcomes description",
            "Medical interventions required",
            "Attribution analysis (device vs procedure vs patient)",
            "Comorbidities and contributing factors"
          ]
        },
        {
          "subsection_id": "d4_regulatory_reporting",
          "subsection_name": "Regulatory Reporting Status",
          "description": "Confirmation of regulatory notifications to competent authorities per Article 87",
          "required": true,
          "narrative_length": "1-2 paragraphs",
          "required_elements": [
            "Number of SIs reported",
            "Authorities notified (list)",
            "Reporting timelines compliance",
            "FSN/FSCA status if applicable"
          ]
        },
        {
          "subsection_id": "d5_comparison_risk_management",
          "subsection_name": "Comparison to Previous Period and Risk Management",
          "description": "Statistical comparison to previous period and integration with Risk Management File",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "Previous period SI count and rate",
            "Statistical significance of change",
            "RMF risk IDs addressed",
            "New risks identified or risk reassessment"
          ]
        }
      ],
      "quality_checks": [
        "All SIs accounted for in tables",
        "IMDRF codes verified against official terminology",
        "Attribution percentages sum to 100%",
        "Regulatory reporting timelines confirmed",
        "Cross-references to FSCAs (Section H) if applicable",
        "MDCG standard tables (2, 3, 4) formatted per Annex I specifications"
      ],
      "output_format": "Narrative with embedded MDCG standard tables, no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGHEST"
    },
    {
      "slot_id": "section_e_customer_feedback",
      "slot_name": "Section E - Customer Feedback",
      "section_number": "E",
      "description": "Non-complaint customer feedback including surveys, advisory communications, unsolicited feedback, and user satisfaction data",
      "evidence_requirements": [
        "customer_surveys",
        "advisory_notices",
        "user_communications",
        "field_representative_reports"
      ],
      "regulatory_reference": "EU MDR Article 83 - Post-market surveillance data collection",
      "required": true,
      "data_type": "narrative_with_optional_tables",
      "completion_priority": 5,
      "estimated_time_minutes": 45,
      "agent_assignment": "safety_narrative_agent",
      "sub_sections": [
        {
          "subsection_id": "e1_feedback_sources",
          "subsection_name": "Customer Feedback Mechanisms",
          "description": "Description of feedback collection methods employed during period",
          "required": true,
          "narrative_length": "1-2 paragraphs",
          "feedback_types": [
            "User satisfaction surveys",
            "Advisory communications",
            "Field representative reports",
            "Customer service inquiries",
            "Professional society feedback",
            "Key opinion leader consultations"
          ]
        },
        {
          "subsection_id": "e2_feedback_analysis",
          "subsection_name": "Thematic Analysis and Actions",
          "description": "Qualitative and quantitative analysis of feedback themes with actions taken",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "optional_table": {
            "table_id": "table_6_customer_feedback",
            "table_name": "Table 6. Customer Feedback by Source and Type",
            "columns": [
              {
                "column_id": "feedback_source",
                "column_name": "Feedback Source",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "positive",
                "column_name": "Positive",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "neutral",
                "column_name": "Neutral",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "negative",
                "column_name": "Negative",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "total",
                "column_name": "Total",
                "data_type": "integer",
                "alignment": "right"
              }
            ]
          }
        }
      ],
      "quality_checks": [
        "Feedback distinct from complaints (Section F)",
        "Actions taken documented if issues identified",
        "No safety signals missed (should be in Section D if serious)"
      ],
      "output_format": "Narrative with optional table if structured data available",
      "human_review_required": false
    },
    {
      "slot_id": "section_f_complaints",
      "slot_name": "Section F - Product Complaint Types, Counts, and Rates",
      "section_number": "F",
      "mdcg_reference": "MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE",
      "description": "Comprehensive complaint analysis including categorization, rate calculations, severity classification, root cause analysis, RACT threshold comparison, and regional/severity breakdown",
      "evidence_requirements": [
        "complaint_database_extract",
        "complaint_investigation_reports",
        "root_cause_analysis_data",
        "ract_thresholds_from_rmf",
        "sales_data_for_rate_calculation"
      ],
      "regulatory_reference": "EU MDR Article 83; ISO 13485:2016 Section 8.2.1; MDCG 2020-11; MDCG 2022-21 Annex I Complaints Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 6,
      "estimated_time_minutes": 120,
      "agent_assignment": "safety_narrative_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_safety_analysis.md",
      "sub_sections": [
        {
          "subsection_id": "f1_complaint_summary",
          "subsection_name": "Overall Complaint Summary",
          "description": "Opening statement with total complaints, overall rate, RACT comparison",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "Total complaints",
            "Units distributed",
            "Overall complaint rate (%)",
            "Complaint rate calculation methodology shown",
            "RACT threshold comparison",
            "Threshold breach status"
          ],
          "critical_formatting": "Complaint rates ALWAYS as percentages (X.XXX%), NEVER per 1,000 units"
        },
        {
          "subsection_id": "f2_severity_classification",
          "subsection_name": "Complaint Categorization by Severity",
          "description": "Breakdown of serious vs. non-serious complaints",
          "required": true,
          "narrative_length": "1-2 paragraphs",
          "categories": [
            "Serious (resulted in or could have resulted in serious incident)",
            "Non-serious (performance/quality without patient harm)"
          ],
          "cross_reference": "Section D for serious complaints leading to SIs"
        },
        {
          "subsection_id": "f3_complaint_type_analysis",
          "subsection_name": "Table 7: Complaint Analysis by Type",
          "description": "Detailed breakdown by complaint category with rates and root cause findings",
          "required": true,
          "narrative_length": "3-5 paragraphs",
          "table_required": {
            "table_id": "table_7_complaint_analysis",
            "table_name": "Table 7. Complaint Analysis by Type",
            "columns": [
              {
                "column_id": "complaint_category",
                "column_name": "Complaint Category",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "count",
                "column_name": "Count",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "percent_of_total",
                "column_name": "% of Total",
                "data_type": "percentage",
                "alignment": "right",
                "format": "XX.X%"
              },
              {
                "column_id": "rate_percent",
                "column_name": "Rate (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%"
              },
              {
                "column_id": "serious",
                "column_name": "Serious",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "non_serious",
                "column_name": "Non-Serious",
                "data_type": "integer",
                "alignment": "right"
              }
            ],
            "sort": "descending_by_count",
            "total_row": true,
            "formatting": {
              "percent_of_total": "XX.X% (1 decimal)",
              "rate_percent": "X.XXX% (3 decimals)",
              "total_row": "bold"
            }
          }
        },
        {
          "subsection_id": "f4_complaints_region_severity",
          "subsection_name": "Table 8: Complaints by Region and Seriousness",
          "mdcg_reference": "MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE",
          "description": "MDCG standard table showing complaints distributed by geographic region and severity classification",
          "required": true,
          "table_required": {
            "table_id": "table_8_complaints_region_severity",
            "table_name": "Table 8. Complaints by Region and Seriousness",
            "mdcg_standard": true,
            "columns": [
              {
                "column_id": "region",
                "column_name": "Region",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "serious",
                "column_name": "Serious",
                "data_type": "integer",
                "alignment": "right",
                "description": "Complaints that resulted in or could have resulted in SI"
              },
              {
                "column_id": "non_serious",
                "column_name": "Non-Serious",
                "data_type": "integer",
                "alignment": "right",
                "description": "Performance/quality complaints without patient harm"
              },
              {
                "column_id": "total",
                "column_name": "Total",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "rate_percent",
                "column_name": "Rate (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%",
                "description": "(Total Complaints / Units Distributed in Region) × 100"
              }
            ],
            "standard_regions": [
              "EEA+TR+XI",
              "UK",
              "United States",
              "Canada",
              "Australia",
              "Japan",
              "China",
              "Rest of World",
              "Worldwide"
            ],
            "total_row": true,
            "formatting": {
              "total_row": "bold_worldwide",
              "rate_calculation": "Show for each region based on regional sales from Table 1"
            }
          }
        },
        {
          "subsection_id": "f5_root_cause_analysis",
          "subsection_name": "Root Cause Analysis Summary",
          "description": "Attribution of complaints to device defect, user factors, patient factors, or indeterminate",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "attribution_categories": [
            "Confirmed device defect",
            "User/procedural factor",
            "Patient/biological factor",
            "Indeterminate",
            "Investigation pending"
          ],
          "special_considerations": {
            "culture_media_ivf_devices": "Embryo development is multifactorial; distinguish confirmed product defects (pH out of spec, contamination) from biological variability"
          }
        },
        {
          "subsection_id": "f6_comparison_previous",
          "subsection_name": "Comparison to Previous Period",
          "description": "Statistical comparison of complaint rates between current and previous period",
          "required": true,
          "narrative_length": "1-2 paragraphs",
          "required_elements": [
            "Previous period rate",
            "Current period rate",
            "Absolute and relative change",
            "Statistical significance (p-value)"
          ]
        }
      ],
      "quality_checks": [
        "Complaint rate calculation shown explicitly",
        "Rates presented as percentages NOT per 1,000 units",
        "RACT threshold comparison documented",
        "Attribution percentages logical (device + user + patient + indet = 100%)",
        "Cross-reference to CAPAs (Section I) for device defects",
        "Multi-product PSURs have separate rates per product",
        "MDCG standard Table 8 (region/severity) formatted per Annex I",
        "Regional rates in Table 8 calculated from regional sales in Table 1"
      ],
      "output_format": "Narrative with embedded Tables 7 and 8 (MDCG standard), no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGH"
    },
    {
      "slot_id": "section_g_trending",
      "slot_name": "Section G - Information from Trend Reporting",
      "section_number": "G",
      "mdcg_reference": "MDCG.ANNEXI.TREND_TABLE",
      "description": "Statistical process control trending analysis, signal detection results, PRR/ROR calculations, threshold breach documentation, and Article 88 compliance assessment",
      "evidence_requirements": [
        "monthly_complaint_data",
        "monthly_sales_data",
        "baseline_period_data",
        "statistical_analysis_results",
        "trend_report_filings"
      ],
      "regulatory_reference": "EU MDR Article 88; MDCG 2020-11; Statistical Process Control; MDCG 2022-21 Annex I Trend Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 7,
      "estimated_time_minutes": 150,
      "agent_assignment": "trend_analysis_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_trend_analysis.md",
      "sub_sections": [
        {
          "subsection_id": "g1_methodology",
          "subsection_name": "Trending Methodology",
          "description": "Complete documentation of statistical methods, control limits, baseline establishment, signal criteria",
          "required": true,
          "narrative_length": "3-5 paragraphs",
          "required_elements": [
            "Metrics monitored (overall rate, specific categories)",
            "Monitoring frequency (monthly, quarterly)",
            "Statistical method (SPC p-chart, u-chart, EWMA, CUSUM)",
            "Control limit calculation (formula shown)",
            "Baseline period definition and justification",
            "Signal detection criteria"
          ]
        },
        {
          "subsection_id": "g2_baseline_establishment",
          "subsection_name": "Baseline Rate Establishment",
          "description": "Documentation of baseline calculation with confidence intervals",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "Baseline period dates",
            "Baseline complaints and units",
            "Baseline rate with 95% CI",
            "Justification for baseline period selection",
            "UCL/CL/LCL calculation"
          ]
        },
        {
          "subsection_id": "g3_current_period_results",
          "subsection_name": "Current Period Trending Results",
          "description": "Monthly trending data with control chart interpretation",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "table_required": {
            "table_id": "table_g1_monthly_trending",
            "table_name": "Table G.1. Monthly Complaint Rate Trending Analysis with SPC Limits",
            "columns": [
              {
                "column_id": "month",
                "column_name": "Month",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "units",
                "column_name": "Units",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "complaints",
                "column_name": "Complaints",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "rate_percent",
                "column_name": "Rate (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%"
              },
              {
                "column_id": "ucl_percent",
                "column_name": "UCL (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%"
              },
              {
                "column_id": "cl_percent",
                "column_name": "CL (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%"
              },
              {
                "column_id": "lcl_percent",
                "column_name": "LCL (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "X.XXX%"
              },
              {
                "column_id": "within_limits",
                "column_name": "Within Limits",
                "data_type": "text",
                "alignment": "center"
              },
              {
                "column_id": "signal",
                "column_name": "Signal",
                "data_type": "text",
                "alignment": "center",
                "values": [
                  "✓",
                  "⚠",
                  "✗"
                ]
              }
            ],
            "formatting": {
              "rates": "X.XXX% (3 decimals)",
              "highlight_ucl_breach": "bold rows where rate > UCL",
              "signal_flags": "✓ (normal) / ⚠ (warning) / ✗ (signal)"
            }
          }
        },
        {
          "subsection_id": "g4_event_type_trending",
          "subsection_name": "Event Category Disproportionality Analysis (PRR)",
          "description": "PRR/ROR analysis for specific complaint categories to detect signals",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "table_required": {
            "table_id": "table_g2_prr_analysis",
            "table_name": "Table G.2. Complaint Category Disproportionality Analysis Using PRR",
            "columns": [
              {
                "column_id": "event_category",
                "column_name": "Event Category",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "current_a",
                "column_name": "Current (a)",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "other_b",
                "column_name": "Other (b)",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "baseline_c",
                "column_name": "Baseline (c)",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "other_d",
                "column_name": "Other (d)",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "prr",
                "column_name": "PRR",
                "data_type": "decimal",
                "alignment": "right",
                "format": "X.XX"
              },
              {
                "column_id": "ci_95",
                "column_name": "95% CI",
                "data_type": "text",
                "alignment": "right"
              },
              {
                "column_id": "p_value",
                "column_name": "p-value",
                "data_type": "decimal",
                "alignment": "right",
                "format": "0.XXX"
              },
              {
                "column_id": "signal",
                "column_name": "Signal",
                "data_type": "text",
                "alignment": "center"
              }
            ],
            "signal_criteria": "PRR ≥ 2.0 AND lower CI > 1.0 AND p < 0.05 AND a ≥ 3"
          }
        },
        {
          "subsection_id": "g5_statistical_comparison",
          "subsection_name": "Current vs. Baseline Statistical Comparison",
          "description": "Direct statistical test results comparing periods",
          "required": true,
          "table_required": {
            "table_id": "table_g3_period_comparison",
            "table_name": "Table G.3. Statistical Comparison of Current Period vs. Baseline Period",
            "columns": [
              {
                "column_id": "metric",
                "column_name": "Metric",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "baseline_period",
                "column_name": "Baseline Period",
                "data_type": "text",
                "alignment": "right"
              },
              {
                "column_id": "current_period",
                "column_name": "Current Period",
                "data_type": "text",
                "alignment": "right"
              },
              {
                "column_id": "absolute_change",
                "column_name": "Absolute Δ",
                "data_type": "text",
                "alignment": "right"
              },
              {
                "column_id": "relative_change_percent",
                "column_name": "Relative Δ (%)",
                "data_type": "text",
                "alignment": "right"
              },
              {
                "column_id": "statistical_test",
                "column_name": "Statistical Test",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "p_value",
                "column_name": "p-value",
                "data_type": "decimal",
                "alignment": "right",
                "format": "0.XXX"
              },
              {
                "column_id": "significant",
                "column_name": "Significant",
                "data_type": "text",
                "alignment": "center"
              }
            ]
          }
        },
        {
          "subsection_id": "g6_ract_comparison",
          "subsection_name": "Table G.4: Threshold Breach Assessment",
          "mdcg_reference": "MDCG.ANNEXI.TREND_TABLE",
          "description": "MDCG standard trend table comparing observed metrics to thresholds with conclusions",
          "required": true,
          "narrative_length": "1-2 paragraphs",
          "table_required": {
            "table_id": "table_g4_threshold_breach",
            "table_name": "Table G.4. Trend Table — Metric, Baseline, Current, Threshold, Conclusion",
            "mdcg_standard": true,
            "columns": [
              {
                "column_id": "metric",
                "column_name": "Metric",
                "data_type": "text",
                "alignment": "left",
                "description": "Monitored safety/performance metric"
              },
              {
                "column_id": "baseline",
                "column_name": "Baseline",
                "data_type": "text",
                "alignment": "right",
                "description": "Historical baseline value (with period)"
              },
              {
                "column_id": "current",
                "column_name": "Current",
                "data_type": "text",
                "alignment": "right",
                "description": "Current period observed value"
              },
              {
                "column_id": "threshold",
                "column_name": "Threshold",
                "data_type": "text",
                "alignment": "right",
                "description": "Pre-defined acceptable limit (RACT/UCL/Article 88)"
              },
              {
                "column_id": "threshold_type",
                "column_name": "Type",
                "data_type": "text",
                "alignment": "left",
                "description": "RACT/UCL/Article 88/Benchmark"
              },
              {
                "column_id": "breach",
                "column_name": "Breach",
                "data_type": "text",
                "alignment": "center",
                "values": [
                  "Yes",
                  "No"
                ]
              },
              {
                "column_id": "conclusion",
                "column_name": "Conclusion/Action",
                "data_type": "text",
                "alignment": "left",
                "description": "Trend assessment and action taken"
              }
            ],
            "example_metrics": [
              "Overall Complaint Rate (%)",
              "Serious Incident Rate (%)",
              "Breakage Complaint Rate (%)",
              "UCL Breach Count (monthly)",
              "Article 88 Trend Signal"
            ]
          }
        },
        {
          "subsection_id": "g7_signal_conclusions",
          "subsection_name": "Signal Detection Conclusions and Article 88 Status",
          "description": "Definitive statement on trends detected, signals identified, Article 88 reporting status",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "required_elements": [
            "Clear statement: trends detected OR no trends detected",
            "Supporting statistical evidence",
            "Article 88 criteria assessment",
            "Trend reports filed (references) OR explicit statement none required",
            "Actions taken if signals detected (link to CAPA Section I)"
          ]
        }
      ],
      "quality_checks": [
        "Control limit calculations shown with formulas",
        "Baseline justified (typically 12-24 months)",
        "PRR/ROR calculations verified",
        "Signal criteria consistently applied",
        "Article 88 status explicitly addressed",
        "Statistical methods appropriate for data type",
        "MDCG standard Table G.4 (trend table) formatted per Annex I",
        "All thresholds (RACT, UCL, Article 88) documented in Table G.4"
      ],
      "output_format": "Narrative with multiple embedded tables including MDCG standard Table G.4, no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGH"
    },
    {
      "slot_id": "section_h_fsca",
      "slot_name": "Section H - Information from Field Safety Corrective Actions (FSCA)",
      "section_number": "H",
      "mdcg_reference": "MDCG.ANNEXI.FSCA_TABLE",
      "description": "Complete documentation of all FSCAs including recalls, field modifications, safety notices, effectiveness verification, and closure status with MDCG standard summary table",
      "evidence_requirements": [
        "fsca_documentation",
        "field_safety_notices",
        "effectiveness_verification_data",
        "regulatory_notification_records",
        "retrieval_tracking_data"
      ],
      "regulatory_reference": "EU MDR Articles 83, 89; MDCG 2019-6; MDCG 2022-21 Annex I FSCA Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 8,
      "estimated_time_minutes": 120,
      "agent_assignment": "fsca_narrative_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_fsca_documentation.md",
      "sub_sections": [
        {
          "subsection_id": "h1_fsca_summary",
          "subsection_name": "FSCA Summary",
          "description": "Overview of all FSCAs during period with categorization and status",
          "required": true,
          "narrative_length": "2-3 paragraphs (if FSCAs) or 1 paragraph (if none)",
          "fsca_types": [
            "Product Recall",
            "FSN Only",
            "Field Modification",
            "Software Update"
          ]
        },
        {
          "subsection_id": "h2_fsca_table",
          "subsection_name": "Table H.1: FSCA Summary Table",
          "mdcg_reference": "MDCG.ANNEXI.FSCA_TABLE",
          "description": "MDCG standard table documenting all FSCAs with identifiers, reasons, dates, regions, and status",
          "required": "conditional:fsca_count_greater_than_zero",
          "table_required": {
            "table_id": "table_h1_fsca_summary",
            "table_name": "Table H.1. Field Safety Corrective Actions Summary",
            "mdcg_standard": true,
            "columns": [
              {
                "column_id": "fsca_identifier",
                "column_name": "FSCA Identifier",
                "data_type": "text",
                "alignment": "left",
                "description": "Unique FSCA reference number"
              },
              {
                "column_id": "type",
                "column_name": "Type",
                "data_type": "text",
                "alignment": "left",
                "values": [
                  "Recall",
                  "FSN Only",
                  "Field Modification",
                  "Software Update"
                ]
              },
              {
                "column_id": "reason",
                "column_name": "Reason/Safety Issue",
                "data_type": "text",
                "alignment": "left",
                "description": "Brief description of safety issue"
              },
              {
                "column_id": "initiation_date",
                "column_name": "Initiation Date",
                "data_type": "date",
                "alignment": "left",
                "format": "DD MMM YYYY"
              },
              {
                "column_id": "affected_regions",
                "column_name": "Affected Regions",
                "data_type": "text",
                "alignment": "left",
                "description": "Geographic scope (EU, US, Global, etc.)"
              },
              {
                "column_id": "affected_units",
                "column_name": "Affected Units",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "effectiveness_percent",
                "column_name": "Effectiveness (%)",
                "data_type": "percentage",
                "alignment": "right",
                "format": "XX.X%",
                "description": "Retrieval/correction rate"
              },
              {
                "column_id": "status",
                "column_name": "Status",
                "data_type": "text",
                "alignment": "left",
                "values": [
                  "Ongoing",
                  "Completed",
                  "Closed"
                ]
              },
              {
                "column_id": "closure_date",
                "column_name": "Closure Date",
                "data_type": "date",
                "alignment": "left",
                "format": "DD MMM YYYY"
              }
            ],
            "formatting": {
              "date_format": "DD MMM YYYY",
              "effectiveness_calculation": "(Units Retrieved or Corrected / Units Distributed) × 100"
            }
          }
        },
        {
          "subsection_id": "h3_individual_fsca",
          "subsection_name": "Individual FSCA Documentation",
          "description": "Complete structured narrative for each FSCA",
          "required": "conditional:fsca_count_greater_than_zero",
          "narrative_length": "4-8 paragraphs per FSCA",
          "required_elements_per_fsca": [
            "FSCA reference and type",
            "Safety issue and rationale",
            "Affected devices (lots, quantities, regions)",
            "Regulatory notifications with dates",
            "FSN details (reference, distribution date, recipients)",
            "User actions required",
            "Effectiveness verification methodology and results",
            "Closure status and justification OR ongoing status with timeline",
            "Integration with SI/CAPA/RMF"
          ]
        },
        {
          "subsection_id": "h4_effectiveness_verification",
          "subsection_name": "Effectiveness Verification",
          "description": "Detailed methodology and results for each FSCA effectiveness check",
          "required": "conditional:fsca_count_greater_than_zero",
          "effectiveness_metrics": [
            "Retrieval rate (% of distributed units returned)",
            "Modification completion rate",
            "FSN distribution confirmation rate",
            "Residual devices in field with risk assessment"
          ]
        },
        {
          "subsection_id": "h5_fsca_conclusions",
          "subsection_name": "Overall FSCA Conclusions",
          "description": "Synthesis of FSCA program effectiveness and patient protection",
          "required": true,
          "narrative_length": "2-4 paragraphs"
        }
      ],
      "quality_checks": [
        "All FSCAs during period documented",
        "Effectiveness rates calculated correctly",
        "Residual risk assessed for incomplete retrievals",
        "Regulatory reporting timelines confirmed",
        "Cross-reference to Section D (SIs) and Section I (CAPAs)",
        "Closure justification evidence-based",
        "MDCG standard Table H.1 formatted per Annex I specifications",
        "All FSCAs in narrative also present in Table H.1"
      ],
      "output_format": "Narrative with MDCG standard Table H.1, no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGHEST"
    },
    {
      "slot_id": "section_i_capa",
      "slot_name": "Section I - Corrective and Preventive Actions",
      "section_number": "I",
      "mdcg_reference": "MDCG.ANNEXI.CAPA_TABLE",
      "description": "Systematic documentation of all CAPAs triggered by PMS findings including root cause analysis, actions implemented, effectiveness verification, and MDCG standard summary table",
      "evidence_requirements": [
        "capa_database_extract",
        "root_cause_analysis_reports",
        "effectiveness_verification_records",
        "documentation_update_logs",
        "rmf_update_records"
      ],
      "regulatory_reference": "ISO 13485:2016 Section 8.5; EU MDR Annex III; FDA 21 CFR 820.100; MDCG 2022-21 Annex I CAPA Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 9,
      "estimated_time_minutes": 180,
      "agent_assignment": "capa_documentation_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_capa_documentation.md",
      "sub_sections": [
        {
          "subsection_id": "i1_capa_summary",
          "subsection_name": "CAPA Program Summary",
          "description": "Overview of all CAPAs initiated with categorization and metrics",
          "required": true,
          "narrative_length": "2-4 paragraphs (if CAPAs) or 1-2 paragraphs (if none)",
          "summary_metrics": [
            "Total CAPAs initiated",
            "Categorization by type (corrective/preventive/combined)",
            "Categorization by trigger (complaints, SIs, trends, audits)",
            "Categorization by category (manufacturing, design, supplier, training)",
            "Status distribution (closed, in progress, open)",
            "Average time to closure",
            "On-time completion rate",
            "Recurrence rate"
          ]
        },
        {
          "subsection_id": "i2_capa_table",
          "subsection_name": "Table I.1: CAPA Summary Table",
          "mdcg_reference": "MDCG.ANNEXI.CAPA_TABLE",
          "description": "MDCG standard table documenting all CAPAs with identifiers, triggers, root causes, actions, effectiveness, and status",
          "required": "conditional:capa_count_greater_than_zero",
          "table_required": {
            "table_id": "table_i1_capa_summary",
            "table_name": "Table I.1. Corrective and Preventive Actions Summary",
            "mdcg_standard": true,
            "columns": [
              {
                "column_id": "capa_identifier",
                "column_name": "CAPA Identifier",
                "data_type": "text",
                "alignment": "left",
                "description": "Unique CAPA reference number"
              },
              {
                "column_id": "trigger",
                "column_name": "Trigger/Source",
                "data_type": "text",
                "alignment": "left",
                "description": "PMS finding that initiated CAPA (complaint, SI, trend, etc.)"
              },
              {
                "column_id": "root_cause",
                "column_name": "Root Cause Summary",
                "data_type": "text",
                "alignment": "left",
                "description": "Brief statement of determined root cause"
              },
              {
                "column_id": "corrective_action",
                "column_name": "Corrective Action(s)",
                "data_type": "text",
                "alignment": "left",
                "description": "Actions to address immediate issue"
              },
              {
                "column_id": "preventive_action",
                "column_name": "Preventive Action(s)",
                "data_type": "text",
                "alignment": "left",
                "description": "Actions to prevent recurrence"
              },
              {
                "column_id": "effectiveness",
                "column_name": "Effectiveness Verified",
                "data_type": "text",
                "alignment": "center",
                "values": [
                  "Yes",
                  "No",
                  "Pending"
                ]
              },
              {
                "column_id": "status",
                "column_name": "Status",
                "data_type": "text",
                "alignment": "left",
                "values": [
                  "Open",
                  "In Progress",
                  "Closed"
                ]
              },
              {
                "column_id": "completion_date",
                "column_name": "Completion Date",
                "data_type": "date",
                "alignment": "left",
                "format": "DD MMM YYYY"
              }
            ],
            "formatting": {
              "date_format": "DD MMM YYYY",
              "text_wrapping": "Allow multi-line text in action columns for readability"
            }
          }
        },
        {
          "subsection_id": "i3_individual_capa",
          "subsection_name": "Individual CAPA Documentation",
          "description": "Complete structured narrative for each significant CAPA",
          "required": "conditional:capa_count_greater_than_zero",
          "narrative_length": "8-12 paragraphs per CAPA",
          "required_elements_per_capa": [
            "CAPA reference, type, category, priority, dates, owner",
            "Triggering event (link to specific PMS finding)",
            "Problem statement (5W2H)",
            "Root cause analysis (methodology, investigation, findings)",
            "Risk assessment (pre/post CAPA)",
            "Corrective actions (containment and root cause correction)",
            "Preventive actions (prevent recurrence)",
            "Documentation updates (RMF, procedures, training, specs)",
            "Implementation status and timeline",
            "Effectiveness verification (methodology, criteria, results)",
            "Integration with PMS (links to Sections D, F, G, H)"
          ],
          "root_cause_methodologies": [
            "5-Why Analysis",
            "Ishikawa (Fishbone) Diagram",
            "8D Problem Solving",
            "FMEA",
            "Apollo RCA"
          ]
        },
        {
          "subsection_id": "i4_capa_program_assessment",
          "subsection_name": "CAPA Program Performance Assessment",
          "description": "Overall evaluation of CAPA program effectiveness and quality system maturity",
          "required": true,
          "narrative_length": "3-5 paragraphs",
          "includes_trending_table": true,
          "quality_system_maturity_indicators": [
            "CAPA volume trend (increasing/stable/decreasing)",
            "Closure time trends",
            "Recurrence rate (same issue requiring new CAPA)",
            "Preventive action rate",
            "Horizontal deployment effectiveness"
          ]
        }
      ],
      "quality_checks": [
        "All CAPAs from PMS findings documented",
        "Root cause verified not assumed",
        "Effectiveness verification completed before closure",
        "Links to triggering PMS findings clear",
        "RMF updates documented",
        "Regulatory compliance confirmed (ISO 13485, EU MDR, FDA)",
        "MDCG standard Table I.1 formatted per Annex I specifications",
        "All CAPAs in narrative also present in Table I.1"
      ],
      "output_format": "Narrative with MDCG standard Table I.1, no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGH"
    },
    {
      "slot_id": "section_j_literature",
      "slot_name": "Section J - Scientific Literature Review",
      "section_number": "J",
      "description": "Systematic literature search results, relevant publications identified, safety signals from literature, and state-of-the-art assessment",
      "evidence_requirements": [
        "literature_search_results",
        "publication_abstracts",
        "full_text_articles_reviewed",
        "safety_signal_assessments",
        "sota_evaluation"
      ],
      "regulatory_reference": "EU MDR Annex XIV Part A; MEDDEV 2.7/1 Rev 4; PRISMA methodology",
      "required": true,
      "data_type": "narrative",
      "completion_priority": 11,
      "estimated_time_minutes": 90,
      "agent_assignment": "clinical_narrative_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_clinical_evidence.md",
      "sub_sections": [
        {
          "subsection_id": "j1_search_methodology",
          "subsection_name": "Literature Search Methodology",
          "description": "Complete documentation of systematic search strategy ensuring reproducibility",
          "required": true,
          "narrative_length": "3-4 paragraphs",
          "required_elements": [
            "Databases searched (PubMed, Embase, Cochrane, etc.)",
            "Search period covered",
            "Search strings/terms used",
            "MeSH terms/Emtree terms",
            "Inclusion criteria",
            "Exclusion criteria",
            "Language and publication type filters"
          ]
        },
        {
          "subsection_id": "j2_search_results",
          "subsection_name": "Search Results and Screening",
          "description": "PRISMA-style quantitative flow of search results",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "Total citations retrieved",
            "Duplicates removed",
            "Citations screened (title/abstract)",
            "Full-text articles assessed",
            "Relevant publications included",
            "Reasons for exclusion at each stage"
          ]
        },
        {
          "subsection_id": "j3_relevant_publications",
          "subsection_name": "Relevant Publications Summary",
          "description": "Structured summary of included publications with key findings",
          "required": true,
          "narrative_length": "Variable based on publication count",
          "format_options": [
            "If 0 publications: 2-3 paragraphs explaining absence and alternative evidence",
            "If 1-5 publications: Structured summary per publication (author, year, title, journal, study design, key findings)",
            "If 6+ publications: Categorized thematic summary with representative citations"
          ]
        },
        {
          "subsection_id": "j4_safety_performance_findings",
          "subsection_name": "Clinical Findings Analysis",
          "description": "Analysis of safety signals, performance data, and state-of-the-art assessment from literature",
          "required": true,
          "narrative_length": "3-5 paragraphs",
          "required_elements": [
            "Safety profile from literature",
            "Performance and clinical outcomes",
            "State-of-the-art evaluation",
            "Consistency with manufacturer's data"
          ]
        },
        {
          "subsection_id": "j5_literature_conclusions",
          "subsection_name": "Conclusions from Literature Review",
          "description": "Synthesis statement on literature findings and CER update status",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "Safety conclusion from literature",
            "Performance conclusion",
            "State-of-the-art status",
            "Impact on benefit-risk",
            "CER update status"
          ]
        }
      ],
      "quality_checks": [
        "Search methodology reproducible",
        "Inclusion/exclusion criteria clearly defined",
        "Publication counts reconcile (retrieved - duplicates - excluded = included)",
        "Safety signals identified or explicitly stated none found",
        "State-of-the-art assessment completed",
        "CER update implications addressed"
      ],
      "output_format": "Narrative only, no inline citations",
      "human_review_required": false
    },
    {
      "slot_id": "section_k_external_databases",
      "slot_name": "Section K - Review of External Databases and Registries",
      "section_number": "K",
      "description": "Systematic search of external regulatory databases (FDA MAUDE, EUDAMED, Health Canada, MHRA, etc.) with comparison to manufacturer's internal data",
      "evidence_requirements": [
        "database_search_results",
        "maude_reports",
        "eudamed_data",
        "health_canada_data",
        "mhra_data",
        "adverse_event_assessments"
      ],
      "regulatory_reference": "EU MDR Article 83 - Post-market surveillance data sources",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 12,
      "estimated_time_minutes": 60,
      "agent_assignment": "clinical_narrative_agent",
      "sub_sections": [
        {
          "subsection_id": "k1_databases_methodology",
          "subsection_name": "Databases Searched and Methodology",
          "description": "Enumeration of all databases searched with search strategy",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "standard_databases": [
            "FDA MAUDE",
            "EUDAMED",
            "Health Canada",
            "MHRA",
            "BfArM",
            "ANSM",
            "Other national databases"
          ],
          "required_elements": [
            "Database list with scope/coverage",
            "Search dates",
            "Search terms/criteria",
            "Time period covered"
          ]
        },
        {
          "subsection_id": "k2_search_results",
          "subsection_name": "Search Results Summary",
          "description": "Quantitative results from each database",
          "required": true,
          "table_required": {
            "table_id": "table_10_external_databases",
            "table_name": "Table 10. External Database Adverse Events Summary",
            "columns": [
              {
                "column_id": "database",
                "column_name": "Database",
                "data_type": "text",
                "alignment": "left"
              },
              {
                "column_id": "total_matches",
                "column_name": "Total Matches",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "relevant_reports",
                "column_name": "Relevant Reports",
                "data_type": "integer",
                "alignment": "right"
              },
              {
                "column_id": "event_categories",
                "column_name": "Event Categories Identified",
                "data_type": "text",
                "alignment": "left"
              }
            ]
          }
        },
        {
          "subsection_id": "k3_findings_analysis",
          "subsection_name": "Analysis of External Database Findings",
          "description": "Thematic analysis and comparison to manufacturer's internal data",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "required_elements": [
            "Event category breakdown",
            "Severity assessment",
            "Novel signals (not in manufacturer's data)",
            "Duplicate reports (also in manufacturer's system)",
            "Consistency assessment"
          ]
        },
        {
          "subsection_id": "k4_database_conclusions",
          "subsection_name": "Conclusions from External Database Review",
          "description": "Synthesis on signal detection and data consistency",
          "required": true,
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "New signals identified (yes/no with details)",
            "Data consistency with internal surveillance",
            "Gaps in manufacturer's complaint capture (if identified)",
            "Overall conclusions on external verification"
          ]
        }
      ],
      "quality_checks": [
        "All major databases searched (MAUDE, EUDAMED minimum)",
        "Duplicate vs. novel reports distinguished",
        "Consistency with internal data assessed",
        "Novel signals investigated and documented",
        "Table 10 totals reconcile"
      ],
      "output_format": "Narrative with embedded Table 10, no inline citations",
      "human_review_required": false
    },
    {
      "slot_id": "section_l_pmcf",
      "slot_name": "Section L - Post-Market Clinical Follow-Up (PMCF)",
      "section_number": "L",
      "mdcg_reference": "MDCG.ANNEXI.PMCF_SUMMARY and MDCG.ANNEXI.PMCF_TABLE",
      "description": "PMCF plan summary, activities conducted, enrollment status, key findings, integration into CER/RMF, or justification if PMCF not required (Article 86.1 main findings and updates required)",
      "evidence_requirements": [
        "pmcf_plan",
        "pmcf_study_protocol",
        "enrollment_data",
        "pmcf_interim_results",
        "pmcf_final_report",
        "pmcf_not_required_justification",
        "cer_rmf_update_status"
      ],
      "regulatory_reference": "EU MDR Annex XIV Part B; MDCG 2020-6; MEDDEV 2.7/1 Rev 4; MDCG 2022-21 Annex I PMCF Summary and Table",
      "required": true,
      "data_type": "narrative_with_tables",
      "completion_priority": 13,
      "estimated_time_minutes": 90,
      "agent_assignment": "clinical_narrative_agent",
      "sub_sections": [
        {
          "subsection_id": "l1_pmcf_status",
          "subsection_name": "PMCF Status and Rationale",
          "mdcg_reference": "MDCG.ANNEXI.PMCF_SUMMARY",
          "description": "Clear statement on PMCF requirement status with justification and Article 86.1 main findings",
          "required": true,
          "narrative_length": "Variable based on scenario",
          "scenarios": [
            {
              "scenario": "pmcf_not_required",
              "narrative_length": "4-6 paragraphs",
              "required_elements": [
                "Device classification and risk profile",
                "Well-established technology rationale",
                "Adequate passive surveillance justification per MDCG 2020-6",
                "Proportionality assessment",
                "Ongoing assessment commitment"
              ]
            },
            {
              "scenario": "pmcf_active_study",
              "narrative_length": "6-10 paragraphs",
              "required_elements": [
                "PMCF Plan summary and rationale",
                "Study design and methods",
                "Enrollment status",
                "Data collection progress",
                "Interim results (if available)",
                "Integration into CER/RMF (Article 86.1)",
                "Next steps and timeline"
              ]
            },
            {
              "scenario": "pmcf_planned_not_initiated",
              "narrative_length": "2-3 paragraphs",
              "required_elements": [
                "PMCF Plan approval date",
                "Planned initiation timeline",
                "Interim data collection activities",
                "Status update"
              ]
            }
          ]
        },
        {
          "subsection_id": "l2_pmcf_design",
          "subsection_name": "PMCF Study Design and Methods",
          "description": "Detailed study design for active PMCF",
          "required": "conditional:pmcf_active",
          "narrative_length": "3-4 paragraphs",
          "required_elements": [
            "Study type (observational, registry, RCT, etc.)",
            "Population and sample size",
            "Primary and secondary endpoints",
            "Data collection methods",
            "Study sites and geographic scope"
          ]
        },
        {
          "subsection_id": "l3_pmcf_table",
          "subsection_name": "Table 11: PMCF Activities and Findings",
          "mdcg_reference": "MDCG.ANNEXI.PMCF_TABLE",
          "description": "MDCG standard table documenting PMCF activities, key findings, impact on safety/performance, and updates required to CER/RMF",
          "required": "conditional:pmcf_active_with_data",
          "table_required": {
            "table_id": "table_11_pmcf_activities",
            "table_name": "Table 11. Post-Market Clinical Follow-Up — Activities, Findings, Impact, Updates Required",
            "mdcg_standard": true,
            "columns": [
              {
                "column_id": "pmcf_activity",
                "column_name": "PMCF Activity",
                "data_type": "text",
                "alignment": "left",
                "description": "Description of PMCF activity or study"
              },
              {
                "column_id": "key_findings",
                "column_name": "Key Findings",
                "data_type": "text",
                "alignment": "left",
                "description": "Summary of main findings from PMCF activity"
              },
              {
                "column_id": "impact_safety_performance",
                "column_name": "Impact on Safety/Performance",
                "data_type": "text",
                "alignment": "left",
                "description": "How findings affect device safety and performance assessment"
              },
              {
                "column_id": "updates_required",
                "column_name": "Updates Required (CER/RMF/IFU)",
                "data_type": "text",
                "alignment": "left",
                "description": "Documentation updates needed based on findings"
              }
            ],
            "formatting": {
              "text_wrapping": "Allow multi-line text for comprehensive information",
              "example_activities": [
                "Post-market registry enrollment",
                "Interim safety analysis",
                "12-month follow-up data collection",
                "Literature review integration",
                "Final study report"
              ]
            }
          }
        },
        {
          "subsection_id": "l4_pmcf_impact",
          "subsection_name": "Integration into CER/RMF (Article 86.1 Updates)",
          "mdcg_reference": "MDCG.ANNEXI.PMCF_SUMMARY",
          "description": "How PMCF findings integrate into Clinical Evaluation Report and Risk Management File per Article 86.1 requirements",
          "required": "conditional:pmcf_active_with_data",
          "narrative_length": "2-3 paragraphs",
          "required_elements": [
            "CER updates based on PMCF findings",
            "RMF risk reassessments",
            "Benefit-risk impact",
            "IFU/labeling implications if any"
          ]
        }
      ],
      "quality_checks": [
        "PMCF status clearly stated (required/not required/ongoing/planned)",
        "If not required: justification per MDCG 2020-6 provided",
        "If active: enrollment and progress documented",
        "If results available: findings integrated into conclusions",
        "Article 86.1 updates to CER/RMF explicitly documented",
        "MDCG standard Table 11 formatted per Annex I specifications if data available"
      ],
      "output_format": "Narrative with MDCG standard Table 11 if structured activity data, no inline citations",
      "human_review_required": false
    },
    {
      "slot_id": "section_m_conclusions",
      "slot_name": "Section M - Conclusions",
      "section_number": "M",
      "mdcg_reference": "MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION and MDCG.ANNEXI.ACTIONS_TAKEN",
      "description": "Comprehensive synthesis of all PMS findings with definitive benefit-risk determination (Article 86.1), acceptability changes vs. prior PSUR, data limitations assessment, actions summary, and compliance affirmation",
      "evidence_requirements": [
        "all_previous_sections_synthesis",
        "benefit_risk_assessment",
        "data_limitation_assessment",
        "actions_summary",
        "compliance_checklist"
      ],
      "regulatory_reference": "EU MDR Article 86(3); Article 86.1 Benefit-Risk; MDCG 2022-21 Section M and Annex I Conclusions/Actions",
      "required": true,
      "data_type": "narrative",
      "completion_priority": 14,
      "estimated_time_minutes": 150,
      "agent_assignment": "conclusions_actions_agent",
      "agent_skill_file": "/mnt/skills/public/regulatory/psur_conclusions.md",
      "sub_sections": [
        {
          "subsection_id": "m_a_benefit_risk",
          "subsection_name": "M(a) - Benefit-Risk Determination (Article 86.1)",
          "mdcg_reference": "MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION",
          "description": "Definitive conclusion on benefit-risk status with comprehensive supporting evidence from all PMS sections and acceptability changes vs. prior PSUR",
          "required": true,
          "narrative_length": "3-5 paragraphs",
          "checkbox_required": true,
          "checkbox_options": [
            "has NOT been adversely impacted and remains UNCHANGED",
            "has been adversely impacted"
          ],
          "required_elements": [
            "Checkbox selection",
            "Units distributed and patient exposure",
            "Safety profile summary (SIs, complaints, rates)",
            "Performance profile summary (PMCF, literature)",
            "Trending analysis summary",
            "FSCA summary if applicable",
            "Benefit achievement confirmation",
            "Risk profile status",
            "Acceptability changes vs. prior PSUR (explicitly state if different from previous determination)",
            "Definitive conclusion statement"
          ]
        },
        {
          "subsection_id": "m_b_benefits_achieved",
          "subsection_name": "M(b) - Achievement of Intended Benefits",
          "description": "Evidence-based confirmation that device achieves intended clinical benefits",
          "required": true,
          "narrative_length": "3-4 paragraphs",
          "required_elements": [
            "Intended benefits stated (from IFU/CER)",
            "Evidence of benefit achievement (PMCF, literature, feedback, low performance complaints)",
            "Any limitations on benefit achievement",
            "Conclusion on benefit delivery"
          ]
        },
        {
          "subsection_id": "m_c_data_limitations",
          "subsection_name": "M(c) - Data Limitations",
          "description": "Honest, transparent assessment of data gaps and their impact on conclusions",
          "required": true,
          "narrative_length": "2-4 paragraphs",
          "limitation_categories": [
            "Sales and distribution data",
            "Complaint and vigilance data",
            "Serious incident data",
            "Clinical performance data",
            "Literature and scientific data",
            "External database data",
            "PMCF data",
            "Population exposure data"
          ],
          "required_elements": [
            "Specific limitations identified",
            "Why limitations exist (factual justification)",
            "Mitigation/alternative evidence",
            "Impact assessment on conclusions",
            "Acceptability for regulatory decision"
          ]
        },
        {
          "subsection_id": "m_d_new_risks_benefits",
          "subsection_name": "M(d) - New or Emerging Risks and Benefits",
          "description": "Documentation of any new risks or benefits identified during surveillance period",
          "required": true,
          "narrative_length": "2-5 paragraphs",
          "scenarios": [
            {
              "scenario": "no_new_risks_or_benefits",
              "narrative_length": "2 paragraphs",
              "required_elements": [
                "Explicit statement no new risks identified",
                "Confirmation RMF remains current",
                "Statement no new benefits identified"
              ]
            },
            {
              "scenario": "new_risks_identified",
              "narrative_length": "4-5 paragraphs per risk",
              "required_elements": [
                "Risk discovery description",
                "Risk characterization (hazard, probability, severity)",
                "Risk evaluation",
                "Risk control measures implemented",
                "Residual risk assessment",
                "RMF update reference",
                "Impact on benefit-risk"
              ]
            }
          ]
        },
        {
          "subsection_id": "m_e_actions_summary",
          "subsection_name": "M(e) - Actions Taken or Recommended",
          "mdcg_reference": "MDCG.ANNEXI.ACTIONS_TAKEN",
          "description": "Comprehensive summary of all preventive/corrective actions, labeling/IFU changes, RMF/CER updates from entire PSUR",
          "required": true,
          "narrative_length": "4-8 paragraphs",
          "required_elements": [
            "CAPAs summary (from Section I)",
            "FSCAs summary (from Section H)",
            "Documentation updates (RMF, CER, PMS Plan, IFU)",
            "Labeling/IFU changes specifically called out",
            "Manufacturing process improvements",
            "Supplier controls",
            "Regulatory notifications",
            "Actions planned for next period",
            "Next PSUR date commitment"
          ]
        },
        {
          "subsection_id": "m_f_overall_conclusion",
          "subsection_name": "M(f) - Overall Performance and Safety Conclusion",
          "description": "Definitive final conclusion affirming safety, performance, benefit-risk, compliance, and continued market authorization",
          "required": true,
          "narrative_length": "4-6 paragraphs",
          "required_elements": [
            "Safety conclusion (quantitative support)",
            "Performance conclusion",
            "Benefit-risk profile confirmation",
            "QMS and PMS adequacy confirmation",
            "Regulatory compliance affirmation (Articles 83, 87, 88)",
            "Continued market authorization statement",
            "Ongoing surveillance commitment",
            "Final compliance statement"
          ],
          "regulatory_criticality": "HIGHEST"
        }
      ],
      "quality_checks": [
        "All six subsections (M(a) through M(f)) present",
        "Benefit-risk checkbox selected in M(a)",
        "Acceptability changes vs. prior PSUR explicitly addressed in M(a)",
        "Quantitative data supporting conclusions",
        "All PMS sections synthesized",
        "Actions from Sections I and H summarized in M(e)",
        "Labeling/IFU changes specifically documented in M(e)",
        "RMF/CER updates listed in M(e)",
        "Documentation updates listed",
        "Compliance affirmation explicit",
        "No ambiguity on continued market authorization"
      ],
      "output_format": "Narrative with checkboxes in M(a), no inline citations",
      "human_review_required": true,
      "regulatory_criticality": "HIGHEST"
    }
  ],
  "optional_appendices": [
    {
      "appendix_id": "appendix_a_abbreviations",
      "appendix_name": "Appendix A - List of Abbreviations",
      "description": "Alphabetical list of all abbreviations used in PSUR",
      "required": false,
      "recommended": true
    },
    {
      "appendix_id": "appendix_b_references",
      "appendix_name": "Appendix B - References",
      "description": "List of regulatory references, standards, and cited documents",
      "required": false,
      "recommended": true
    },
    {
      "appendix_id": "appendix_c_attachments",
      "appendix_name": "Appendix C - Attachments",
      "description": "Supporting documentation (trend reports, FSCA reports, etc.)",
      "required": false
    }
  ],
  "mdcg_annex_i_compliance": {
    "standard_sections_covered": [
      "MDCG.ANNEXI.TOC - Table of Contents",
      "MDCG.ANNEXI.SALES_TABLE - Exposure table by region (Table 1)",
      "MDCG.ANNEXI.SERIOUS_INCIDENTS_TABLE_IMDRF - IMDRF coding tables (Tables 2, 3, 4)",
      "MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE - Complaints by region/severity (Table 8)",
      "MDCG.ANNEXI.TREND_TABLE - Trend threshold breach table (Table G.4)",
      "MDCG.ANNEXI.FSCA_TABLE - FSCA summary table (Table H.1)",
      "MDCG.ANNEXI.CAPA_TABLE - CAPA summary table (Table I.1)",
      "MDCG.ANNEXI.PMCF_SUMMARY - PMCF activities/findings narrative (Section L)",
      "MDCG.ANNEXI.PMCF_TABLE - PMCF activities/impact table (Table 11)",
      "MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION - Benefit-risk determination (Section M(a))",
      "MDCG.ANNEXI.ACTIONS_TAKEN - Actions summary (Section M(e))"
    ],
    "mapping": {
      "MDCG.ANNEXI.TOC": "mdcg_toc",
      "MDCG.ANNEXI.SALES_TABLE": "section_c_sales_distribution.c2_sales_tables",
      "MDCG.ANNEXI.SERIOUS_INCIDENTS_TABLE_IMDRF": "section_d_serious_incidents.d2_imdrf_classification",
      "MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE": "section_f_complaints.f4_complaints_region_severity",
      "MDCG.ANNEXI.TREND_TABLE": "section_g_trending.g6_ract_comparison",
      "MDCG.ANNEXI.FSCA_TABLE": "section_h_fsca.h2_fsca_table",
      "MDCG.ANNEXI.CAPA_TABLE": "section_i_capa.i2_capa_table",
      "MDCG.ANNEXI.PMCF_SUMMARY": "section_l_pmcf.l1_pmcf_status",
      "MDCG.ANNEXI.PMCF_TABLE": "section_l_pmcf.l3_pmcf_table",
      "MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION": "section_m_conclusions.m_a_benefit_risk",
      "MDCG.ANNEXI.ACTIONS_TAKEN": "section_m_conclusions.m_e_actions_summary"
    },
    "verification_checklist": [
      "Table of Contents auto-generated with all sections",
      "Table 1 includes exposure estimates (population exposure column)",
      "Tables 2, 3, 4 use exact IMDRF terminology and coding",
      "Table 8 shows complaints by region with serious/non-serious breakdown",
      "Table G.4 documents all thresholds (RACT/UCL/Article 88) with breach status",
      "Table H.1 documents all FSCAs with effectiveness percentages",
      "Table I.1 documents all CAPAs with root causes and effectiveness",
      "Section L addresses PMCF per Article 86.1 requirements",
      "Table 11 shows PMCF impact on safety/performance and CER/RMF updates",
      "Section M(a) includes acceptability changes vs. prior PSUR",
      "Section M(e) explicitly lists labeling/IFU changes and RMF/CER updates"
    ]
  },
  "workflow": {
    "recommended_sequence": [
      "cover_page",
      "section_b_device_description",
      "section_c_sales_distribution",
      "section_d_serious_incidents",
      "section_f_complaints",
      "section_g_trending",
      "section_e_customer_feedback",
      "section_h_fsca",
      "section_i_capa",
      "section_j_literature",
      "section_k_external_databases",
      "section_l_pmcf",
      "section_m_conclusions",
      "section_a_executive_summary",
      "mdcg_toc"
    ],
    "parallel_processing_groups": [
      {
        "group_id": "safety_data",
        "slots": [
          "section_d_serious_incidents",
          "section_f_complaints",
          "section_g_trending"
        ],
        "can_process_simultaneously": true
      },
      {
        "group_id": "clinical_data",
        "slots": [
          "section_j_literature",
          "section_k_external_databases",
          "section_l_pmcf"
        ],
        "can_process_simultaneously": true
      },
      {
        "group_id": "mdcg_tables",
        "slots": [
          "section_c_sales_distribution.c2_sales_tables",
          "section_d_serious_incidents.d2_imdrf_classification",
          "section_f_complaints.f4_complaints_region_severity",
          "section_g_trending.g6_ract_comparison",
          "section_h_fsca.h2_fsca_table",
          "section_i_capa.i2_capa_table",
          "section_l_pmcf.l3_pmcf_table"
        ],
        "description": "MDCG standard tables can be generated once data is available",
        "can_process_simultaneously": true
      }
    ],
    "dependencies": [
      {
        "slot": "mdcg_toc",
        "depends_on": [
          "all_sections"
        ],
        "reason": "Table of Contents must be generated last after all sections complete"
      },
      {
        "slot": "section_a_executive_summary",
        "depends_on": [
          "section_d_serious_incidents",
          "section_f_complaints",
          "section_g_trending",
          "section_h_fsca",
          "section_m_conclusions"
        ],
        "reason": "Executive summary synthesizes all findings; must be completed near last"
      },
      {
        "slot": "section_m_conclusions",
        "depends_on": [
          "all_sections_d_through_l"
        ],
        "reason": "Conclusions synthesize all PMS data"
      },
      {
        "slot": "section_g_trending",
        "depends_on": [
          "section_c_sales_distribution",
          "section_f_complaints"
        ],
        "reason": "Trending requires sales data for rate calculations"
      },
      {
        "slot": "section_f_complaints.f4_complaints_region_severity",
        "depends_on": [
          "section_c_sales_distribution.c2_sales_tables"
        ],
        "reason": "Table 8 regional complaint rates require regional sales data from Table 1"
      }
    ]
  },
  "validation_rules": {
    "cross_section_consistency": [
      {
        "rule_id": "si_count_consistency",
        "description": "SI count in Section A must match Section D",
        "sections": [
          "section_a_executive_summary",
          "section_d_serious_incidents"
        ],
        "validation": "section_a.si_count == section_d.si_count"
      },
      {
        "rule_id": "complaint_rate_consistency",
        "description": "Complaint rate in Section A must match Section F",
        "sections": [
          "section_a_executive_summary",
          "section_f_complaints"
        ],
        "validation": "section_a.complaint_rate == section_f.overall_complaint_rate"
      },
      {
        "rule_id": "benefit_risk_consistency",
        "description": "Benefit-risk conclusion in Section A must match Section M(a)",
        "sections": [
          "section_a_executive_summary",
          "section_m_conclusions"
        ],
        "validation": "section_a.benefit_risk_checkbox == section_m.m_a_benefit_risk_checkbox"
      },
      {
        "rule_id": "units_distributed_consistency",
        "description": "Units distributed should be consistent across Sections C, F, G",
        "sections": [
          "section_c_sales_distribution",
          "section_f_complaints",
          "section_g_trending"
        ],
        "validation": "section_c.total_units == section_f.denominator == section_g.denominator"
      },
      {
        "rule_id": "regional_sales_complaints_consistency",
        "description": "Regional complaint rates in Table 8 must use regional sales from Table 1",
        "sections": [
          "section_c_sales_distribution.c2_sales_tables",
          "section_f_complaints.f4_complaints_region_severity"
        ],
        "validation": "table_8.regional_rates calculated from table_1.regional_units"
      },
      {
        "rule_id": "fsca_count_consistency",
        "description": "FSCA count in narrative must match Table H.1 row count",
        "sections": [
          "section_h_fsca.h1_fsca_summary",
          "section_h_fsca.h2_fsca_table"
        ],
        "validation": "narrative.fsca_count == table_h1.row_count"
      },
      {
        "rule_id": "capa_count_consistency",
        "description": "CAPA count in narrative must match Table I.1 row count",
        "sections": [
          "section_i_capa.i1_capa_summary",
          "section_i_capa.i2_capa_table"
        ],
        "validation": "narrative.capa_count == table_i1.row_count"
      },
      {
        "rule_id": "actions_summary_completeness",
        "description": "Section M(e) actions summary must include all FSCAs and CAPAs from Sections H and I",
        "sections": [
          "section_h_fsca",
          "section_i_capa",
          "section_m_conclusions.m_e_actions_summary"
        ],
        "validation": "m_e.fsca_references include all h.fsca_references AND m_e.capa_references include all i.capa_references"
      }
    ],
    "mdcg_table_compliance": [
      {
        "rule_id": "table_1_exposure_column",
        "description": "Table 1 must include exposure estimate column per MDCG Annex I",
        "table": "table_1_sales_exposure",
        "validation": "columns include 'exposure_estimate' OR narrative explains why not applicable"
      },
      {
        "rule_id": "imdrf_tables_present",
        "description": "If SIs > 0, Tables 2, 3, 4 (IMDRF) must be present",
        "tables": [
          "table_2_imdrf_annex_a",
          "table_3_imdrf_annex_c",
          "table_4_imdrf_annex_d"
        ],
        "validation": "IF section_d.si_count > 0 THEN tables 2,3,4 present"
      },
      {
        "rule_id": "table_8_region_severity",
        "description": "Table 8 must have serious/non-serious columns per MDCG Annex I",
        "table": "table_8_complaints_region_severity",
        "validation": "columns include 'serious' AND 'non_serious'"
      },
      {
        "rule_id": "table_g4_threshold_types",
        "description": "Table G.4 must document all threshold types (RACT, UCL, Article 88)",
        "table": "table_g4_threshold_breach",
        "validation": "threshold_type column includes RACT AND UCL AND Article_88 where applicable"
      },
      {
        "rule_id": "table_h1_effectiveness",
        "description": "Table H.1 must include effectiveness percentage for all FSCAs",
        "table": "table_h1_fsca_summary",
        "validation": "columns include 'effectiveness_percent' with values for all rows"
      },
      {
        "rule_id": "table_i1_effectiveness",
        "description": "Table I.1 must include effectiveness verification status for all CAPAs",
        "table": "table_i1_capa_summary",
        "validation": "columns include 'effectiveness' with values (Yes/No/Pending) for all rows"
      },
      {
        "rule_id": "table_11_impact_updates",
        "description": "Table 11 must document impact on safety/performance and CER/RMF updates per MDCG Annex I",
        "table": "table_11_pmcf_activities",
        "validation": "columns include 'impact_safety_performance' AND 'updates_required'"
      }
    ],
    "data_quality_checks": [
      {
        "check_id": "no_citation_markers",
        "description": "No [ATOM-xxx] citation markers in any narrative text",
        "applies_to": "all_narrative_sections",
        "validation_regex": "\\[ATOM-\\d+\\]"
      },
      {
        "check_id": "complaint_rate_format",
        "description": "Complaint rates must be percentages (X.XXX%), not per 1,000 units",
        "applies_to": [
          "section_f_complaints",
          "section_g_trending"
        ],
        "validation": "contains('%') and not contains('per 1,000' or 'per 1000')"
      },
      {
        "check_id": "checkbox_selections",
        "description": "All required checkboxes must have selections",
        "applies_to": [
          "section_a_executive_summary",
          "section_b_device_description",
          "section_m_conclusions"
        ],
        "validation": "checkboxes_not_null"
      },
      {
        "check_id": "imdrf_codes_valid",
        "description": "IMDRF codes in Tables 2, 3, 4 must match official IMDRF terminology",
        "applies_to": [
          "table_2_imdrf_annex_a",
          "table_3_imdrf_annex_c",
          "table_4_imdrf_annex_d"
        ],
        "validation": "codes match IMDRF_official_list"
      },
      {
        "check_id": "percentage_totals",
        "description": "Percentage columns must sum to 100% (or 100.000%)",
        "applies_to": [
          "all_tables_with_percentage_columns"
        ],
        "validation": "sum(percentage_column) == 100.0 within rounding tolerance"
      },
      {
        "check_id": "date_format_consistency",
        "description": "All dates must use DD MMM YYYY format consistently",
        "applies_to": [
          "all_tables_with_date_columns"
        ],
        "validation": "date_format matches 'DD MMM YYYY'"
      },
      {
        "check_id": "m_a_acceptability_changes",
        "description": "Section M(a) must explicitly address acceptability changes vs. prior PSUR",
        "applies_to": [
          "section_m_conclusions.m_a_benefit_risk"
        ],
        "validation": "narrative contains comparison to previous PSUR benefit-risk determination"
      },
      {
        "check_id": "m_e_labeling_ifu_changes",
        "description": "Section M(e) must explicitly list any labeling/IFU changes",
        "applies_to": [
          "section_m_conclusions.m_e_actions_summary"
        ],
        "validation": "narrative explicitly addresses labeling/IFU updates (even if none)"
      },
      {
        "check_id": "l1_article_86_1_updates",
        "description": "Section L must address Article 86.1 updates to CER/RMF from PMCF",
        "applies_to": [
          "section_l_pmcf.l1_pmcf_status",
          "section_l_pmcf.l4_pmcf_impact"
        ],
        "validation": "narrative explicitly addresses CER and RMF updates based on PMCF findings"
      }
    ]
  },
  "compliance_checklist": {
    "eu_mdr_article_86": [
      "Device identification complete (Article 86.1)",
      "Data collection period documented",
      "Sales/distribution data with exposure estimates (Article 86.1)",
      "Serious incidents documented with IMDRF coding",
      "Complaints analyzed by type and region/severity",
      "Trending analysis completed with Article 88 compliance",
      "FSCAs documented if applicable with effectiveness",
      "CAPAs from PMS findings documented with root cause",
      "Literature review conducted systematically",
      "External databases searched",
      "PMCF status addressed with Article 86.1 updates to CER/RMF",
      "Benefit-risk assessment completed (Article 86.1)",
      "Acceptability changes vs. prior PSUR addressed (Article 86.1)",
      "Data limitations acknowledged",
      "Actions taken/planned documented (preventive/corrective, labeling, RMF/CER)",
      "Conclusions definitive and evidence-based"
    ],
    "mdcg_2022_21_template": [
      "All sections A through M present",
      "Section A executive summary comprehensive",
      "Multi-product grouping justified if applicable",
      "IMDRF coding applied to SIs if applicable (Tables 2, 3, 4)",
      "Article 88 trending compliance documented",
      "FSCA effectiveness verified (Table H.1)",
      "CAPA effectiveness verified (Table I.1)",
      "PMCF rationale provided with Article 86.1 CER/RMF updates",
      "Overall conclusions clear and defensible"
    ],
    "mdcg_2022_21_annex_i": [
      "Table of Contents (MDCG.ANNEXI.TOC) auto-generated",
      "Table 1: Sales/Exposure by region (MDCG.ANNEXI.SALES_TABLE)",
      "Tables 2, 3, 4: IMDRF SI tables (MDCG.ANNEXI.SERIOUS_INCIDENTS_TABLE_IMDRF)",
      "Table 8: Complaints by region/severity (MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE)",
      "Table G.4: Trend threshold breach (MDCG.ANNEXI.TREND_TABLE)",
      "Table H.1: FSCA summary (MDCG.ANNEXI.FSCA_TABLE)",
      "Table I.1: CAPA summary (MDCG.ANNEXI.CAPA_TABLE)",
      "Section L: PMCF activities/findings (MDCG.ANNEXI.PMCF_SUMMARY)",
      "Table 11: PMCF impact/updates (MDCG.ANNEXI.PMCF_TABLE)",
      "Section M(a): Benefit-risk with acceptability changes (MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION)",
      "Section M(e): Actions including labeling/RMF/CER (MDCG.ANNEXI.ACTIONS_TAKEN)"
    ]
  },
  "output_specifications": {
    "document_format": "Microsoft Word (.docx) or PDF",
    "font": "Arial 11pt body text, Arial 12pt section headings",
    "line_spacing": "Single space within paragraphs, 6pt space after paragraphs",
    "page_margins": "1.0 inch all sides",
    "page_numbering": "Bottom center, starting from Section A",
    "header_footer": "Header: PSUR reference and device name; Footer: Page number",
    "table_style": "Table Grid, Arial 8-9pt",
    "section_breaks": "Page break before each section A-M",
    "citation_style": "No inline citations; evidence tracking in metadata only",
    "mdcg_table_formatting": {
      "standard_tables_highlighted": "MDCG standard tables (Tables 1, 2-4, 8, G.4, H.1, I.1, 11) use consistent formatting",
      "column_alignment": "Text left, numbers right, flags center per MDCG examples",
      "date_format": "DD MMM YYYY consistently",
      "percentage_precision": "X.XXX% for rates, XX.X% for distributions",
      "bold_totals": "Total/Worldwide rows in bold"
    }
  },
  "quality_assurance": {
    "automated_checks": [
      "Citation marker detection",
      "Cross-section consistency validation",
      "Required field completeness",
      "Checkbox selection verification",
      "Formatting compliance",
      "Calculation verification (rates, percentages)",
      "MDCG table structure validation",
      "IMDRF code validation",
      "Regional sales/complaints alignment",
      "FSCA/CAPA count reconciliation",
      "Article 86.1 requirements verification"
    ],
    "human_review_required": [
      "section_a_executive_summary",
      "section_b_device_description",
      "section_d_serious_incidents",
      "section_f_complaints",
      "section_g_trending",
      "section_h_fsca",
      "section_i_capa",
      "section_m_conclusions"
    ],
    "regulatory_criticality_highest": [
      "section_a_executive_summary",
      "section_d_serious_incidents",
      "section_h_fsca",
      "section_m_conclusions"
    ],
    "mdcg_compliance_review": [
      "All MDCG Annex I standard sections present",
      "All MDCG standard tables formatted correctly",
      "Article 86.1 requirements addressed (exposure, benefit-risk, acceptability changes, CER/RMF updates)",
      "Actions summary comprehensive (preventive/corrective, labeling, documentation)"
    ]
  },
  "metadata_tracking": {
    "evidence_atoms_required": true,
    "confidence_scores_required": true,
    "reasoning_documentation_required": true,
    "data_gap_identification_required": true,
    "source_traceability_required": true,
    "mdcg_table_provenance": {
      "track_data_sources_per_table": true,
      "document_calculation_methods": true,
      "verify_mdcg_standard_compliance": true
    }
  },
  "version_control": {
    "template_version": "3.0",
    "change_log": [
      {
        "version": "3.0",
        "date": "2025-01-25",
        "changes": [
          "Added MDCG 2022-21 Annex I standard sections and tables",
          "Added Table of Contents (MDCG.ANNEXI.TOC)",
          "Added Table 1 exposure estimates column (MDCG.ANNEXI.SALES_TABLE)",
          "Added Table 8 complaints by region/severity (MDCG.ANNEXI.COMPLAINTS_BY_REGION_SEVERITY_TABLE)",
          "Added Table G.4 trend threshold breach (MDCG.ANNEXI.TREND_TABLE)",
          "Added Table H.1 FSCA summary (MDCG.ANNEXI.FSCA_TABLE)",
          "Added Table I.1 CAPA summary (MDCG.ANNEXI.CAPA_TABLE)",
          "Enhanced Section L PMCF with Article 86.1 requirements (MDCG.ANNEXI.PMCF_SUMMARY)",
          "Added Table 11 PMCF activities/impact (MDCG.ANNEXI.PMCF_TABLE)",
          "Enhanced Section M(a) with acceptability changes (MDCG.ANNEXI.BENEFIT_RISK_CONCLUSION)",
          "Enhanced Section M(e) with labeling/RMF/CER updates (MDCG.ANNEXI.ACTIONS_TAKEN)",
          "Added MDCG compliance validation rules",
          "Added cross-references between narrative sections and MDCG standard tables"
        ]
      },
      {
        "version": "2.0",
        "date": "2025-01-25",
        "changes": [
          "Initial comprehensive template with all sections A-M",
          "Detailed sub-section structures",
          "Agent assignments and skill files",
          "Quality checks and validation rules"
        ]
      }
    ]
  }
}